TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE
Evans, Hazel Thornton, and Iain Chalmers
REFERENCES 31 - 60
31 Thornton H. The screening debates: time for a broader approach?
European Journal of
32 Adapted from Wilson JMG, Jungner G. Principles and practice of
disease. Public health paper no 34. Geneva: World Health Organisation,
33 Gray JAM. Evidence-based healthcare. Edinburgh: Churchill
34 Morris JK. Screening for neuroblastoma in children. Journal of
35 Welch HG. Should I be tested for cancer? Maybe not and here’s why.
Berkeley and Los
Angeles: University of California Press, 2004. p77.
36 Morris JK. Screening for neuroblastoma in children. Journal of
Medical Screening 2002;9:56.
37 Hummel S, Paisley S, Morgan A, et al. Clinical and
cost-effectiveness of new and
emerging technologies for early localised prostate cancer: a systematic
Health Technology Assessment Report 2003; volume 7, no. 33.
38 Law M. Screening without evidence of efficacy. British Medical
39 Yamey G, Wilkes M. The PSA storm. British Medical Journal
40 Wallis C. Atypical cystic fibrosis – diagnostic and management
dilemmas. Journal of
the Royal Society of Medicine 2003;96(suppl 43):2–10.
41 David TJ. Newborn screening for cystic fibrosis. Journal of the
Royal Society of Medicine
42 Farrell MH, Farrell PM. Newborn screening for cystic fibrosis:
ensuring more good
than harm. Journal of Pediatrics 2003;143:707–12.
43 NICE. Guidance on the removal of wisdom teeth, 2000. Available from:
www.nice.org.uk/page.aspx?o=526 [accessed 4 December 2005].
44 Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful
more careful evaluation. Lancet 1999;354:1229–33.
45 Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A
comparison of results of meta-analysis of randomized control trials and
recommendations of clinical experts. Journal of the American Medical
46 Asher R. Talking sense (Lettsonian lecture, 16 Feb, 1959).
Transactions of the Medical Society of London, vol LXXV, 1958–59.
Reproduced in: Jones, FA, ed. Richard Asher talking sense. London:
Pitman Medical, 1972.
47 Noseworthy JH, Ebers GC, Vandervoort MK, et al. The impact of
blinding on the results of a randomized, placebo-controlled multiple
sclerosis clinical trial. Neurology 1994;44:16–20.
48 Antiplatelet Trialists’ Collaborative Group. Collaborative overview
of randomised trials of antiplatelet therapy. British Medical Journal
49 Beral V, for the Million Women Study Collaborators. Breast cancer
and hormonereplacement therapy in the Million Women Study. Lancet
50 Address by the Rt. Hon. Lord Rayleigh. In: Report of the
fifty-fourth meeting of the British Association for the Advancement of
Science; held at Montreal in August and September 1884, London: John
51 Reynolds LA, Tansey EM, eds. Prenatal corticosteroids for reducing
morbidity and mortality after preterm birth. London: Wellcome Trust
Centre for the History of Medicine, 2005.
52 Lindley RI. Personal communication, 2005.
53 Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a
specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid
leukemia. New England Journal of Medicine 2001;344:1031–7.
54 Loudon I. The use of historical controls and concurrent controls to
assess the effects of sulphonamides, 1936–1945. Available from:
www.jameslindlibrary.org [accessed 3 January 2006].
55 Transurethral resection of the prostate for benign prostatic
hyperplasia. In: Wennburg JE, McAndrew Cooper M, eds. The Dartmouth
Atlas of Healthcare in the United States. Hanover, New Hampshire:
Center for Evaluative Clinical Sciences, Dartmouth Medical School,
1996, p142. The 1996 edition and the updated 1999 edition are available
from: www.dartmouthatlas.org/atlases/atlas_series.shtm [accessed 29
56 Burton MJ, Towler B, Glasziou P. Tonsillectomy versus non-surgical
chronic/recurrent acute tonsillitis. The Cochrane Database of
Systematic Reviews 1999,
Issue 3. Art. No.: CD001802. Available from: www.thecochranelibrary.com
[accessed 3 January 2006].
57 Ashcroft R. Giving medicine a fair trial. British Medical Journal
58 Smithells RW. Iatrogenic hazards and their effects. Postgraduate
59 General Medical Council. Seeking patients’ consent: the ethical
considerations. November 1998. Available from:
www.gmc-uk.org/guidance/library/consent.asp [accessed 6 December 2005].
60 Chalmers I, Lindley R. Double standards on informed consent to
treatment. In: Doyal L, Tobias JS, eds. Informed consent in medical
research. London: BMJ Books 2001, pp266–75.